Literature DB >> 8923304

Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

C Abbruzzese1, R Krahe, M Liguori, D Tessarolo, M J Siciliano, T Ashizawa, M Giacanelli.   

Abstract

Myotonic dystrophy (DM) is associated with an expansion of an unstable (CTG)n repeat in the 3' untranslated region of the DM protein kinase (DMPK) gene on chromosome 19q13.3. We studied six patients from two families who showed no expansions of the repeat, in spite of their clinical diagnosis of DM. These patients had multi-systemic manifestations that were distinguishable from those seen in other myotonic disorders, including proximal myotonic myopathy (PROMM). In one additional family, two symptomatic members showed no expanded (CTG)n repeats, while their affected relatives had the expanded repeats. DM haplotype analysis failed to exclude the DMPK locus as a possible site of mutation in each family; however, DMPK mRNA levels were normal. We conclude that a mutation(s) other than the expanded (CTG)n repeat can cause the DM phenotype. The mutation(s) in these families remain(s) to be mapped and characterized.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923304     DOI: 10.1007/bf00873977

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Criteria for establishing the validity of genetic recombination in myotonic dystrophy.

Authors:  R C Griggs; D S Wood
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

2.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

3.  Huntington disease without CAG expansion: phenocopies or errors in assignment?

Authors:  S E Andrew; Y P Goldberg; B Kremer; F Squitieri; J Theilmann; J Zeisler; H Telenius; S Adam; E Almquist; M Anvret
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

4.  Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene.

Authors:  L A Sabouri; M S Mahadevan; M Narang; D S Lee; L C Surh; R G Korneluk
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

Review 5.  AAEE minimonograph #27: differential diagnosis of myotonic syndromes.

Authors:  E W Streib
Journal:  Muscle Nerve       Date:  1987-09       Impact factor: 3.217

6.  Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.

Authors:  K Ricker; M C Koch; F Lehmann-Horn; D Pongratz; N Speich; K Reiners; C Schneider; R T Moxley
Journal:  Arch Neurol       Date:  1995-01

7.  Potentially fatal cardiac dysrhythmia and hyperkalemic periodic paralysis.

Authors:  R J Gould; C N Steeg; A B Eastwood; A S Penn; L P Rowland; D C De Vivo
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

8.  Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms.

Authors:  T Ashizawa; J F Hejtmancik; J Liu; M B Perryman; H F Epstein; D D Koch
Journal:  Am J Med Genet       Date:  1992-01-01

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus.

Authors:  G Jansen; D Bächner; M Coerwinkel; N Wormskamp; H Hameister; B Wieringa
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

View more
  2 in total

1.  Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).

Authors:  Claudio Catalli; Alessandra Morgante; Raniero Iraci; Fabrizio Rinaldi; Annalisa Botta; Giuseppe Novelli
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

2.  Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.

Authors:  Linda L Bachinski; Bjarne Udd; Giovanni Meola; Valeria Sansone; Guillaume Bassez; Bruno Eymard; Charles A Thornton; Richard T Moxley; Peter S Harper; Mark T Rogers; Karin Jurkat-Rott; Frank Lehmann-Horn; Thomas Wieser; Josep Gamez; Carmen Navarro; Armand Bottani; Andre Kohler; Mark D Shriver; Riitta Sallinen; Maija Wessman; Shanxiang Zhang; Fred A Wright; Ralf Krahe
Journal:  Am J Hum Genet       Date:  2003-09-10       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.